New agents in clinical development: The search for selectivity
{"Image DocumentName": "New agents in clinical development: The search for selectivity", "Image ImageDescription": "Thrombin Inhibitors: DS, Hirudin, Bivalirudin, Argatroban, Melagatran, Ximelagatran. IXa inhibitors. Xa inhibitors: Pentasaccharide. TAP, Antistasin, DX 9065a, DPC 906. Protein C Activators. aPC, Thrombomodulin. Coagulation Pathway. Antithrombotics in development. Tissue Factor Pathway Inhibitors. TFPI, rNAPc2, VIIa inhibitors. Initiation. Thrombin. generation. activity. TF/VIIa. X. IX. IXa. VIIIa. Xa. Va. II. IIa. i.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}